AI Tech Digest
AiTechDigest
  • Home
  • Categories
    • AI & Machine Learning
    • Future Technologies
    • Tech Industry News
    • Robotics & Automation
    • Quantum Computing
    • Cybersecurity & Privacy
    • Big Data & Analytics
    • Ethics & AI Policy
    • Gadgets & Consumer Tech
    • Space & Aerospace Tech
  • All Posts
  • AI & Machine Learning
  • Future Technologies
  • Tech Industry News
  • Robotics & Automation
  • Quantum Computing
  • Cybersecurity & Privacy
  • Big Data & Analytics
  • Ethics & AI Policy
  • Gadgets & Consumer Tech
  • Space & Aerospace Tech
June 30.2026
2 Minutes Read

NASA's Vision: Sending a Spare Mars Rover to the Moon for Innovation

Sending Mars rover to the Moon concept with detailed machinery outdoors

NASA's Bold Leap: Sending a Mars Rover to the Moon

NASA has unveiled an exciting potential mission: the agency is considering sending spare nuclear-powered Mars rover, known as PROMISE (Polar Rover for Observation, Mapping, and In-Situ Exploration), to the lunar surface. This plan is part of NASA's broader lunar ambitions, which aim to establish a sustainable human presence on the Moon by 2029. The decision to utilize this Mars rover represents a unique merging of technologies and lessons learned from previous missions.

Historical Context: A Return to Lunar Exploration

NASA’s current lunar initiatives draw inspiration from the strategies employed during the Apollo missions of the 1960s when the U.S. raced to the Moon. Similarly, the Artemis program seeks to create a new chapter in space exploration, emphasizing incremental build-up toward a permanent human base. According to NASA Administrator Jared Isaacman, the approach now mirrors that historic strategy: "We didn't just jump right to Apollo 11." This shift reflects the imperatives of modern science and technological advancements, as NASA seeks to extract valuable insights that can be applied to both lunar and Martian exploration.

Why the Moon? Insights on Lunar Expeditions

The selection of the lunar south pole for the Artemis base is strategic. It's believed to hold stores of water ice, which are essential for potential human habitation and can also be used to create fuel. The unique lighting conditions in this area provide an unparalleled opportunity for scientific exploration, making it an ideal candidate for deploying PROMISE on missions that require constant observation and data collection.

Benefits of Utilizing PROMISE on the Moon

PROMISE was not built for lunar exploration directly; however, its capabilities as a test rover offer a promising advantage. Its radioisotope thermoelectric generator (RTG) allows it to function without solar power, a crucial factor for operating in the Moon's shadowy craters. As solar-powered landers face limitations due to the Moon's prolonged darkness in certain regions, the deployment of PROMISE offers a reliable alternative for continuous operation and exploration.

Synergy Between Mars and Lunar Missions

While sending PROMISE to the Moon might create a dilemma for existing rovers on Mars, the value of the data collected from lunar missions could offer profound implications for future Martian expeditions. Insights gained from PROMISE’s operations in the lunar environment could lead to enhancements in understanding the challenges of sustaining life and conducting research on other celestial bodies. It builds a framework for NASA to make advancements on both fronts—paving the way for ambitious missions that could lead humanity further into the cosmos.

What’s Next for NASA?

NASA's bold proposal to repurpose PROMISE comes alongside commitments to ongoing lunar expeditions that prioritize research and innovative technology deployment. As the agency pushes towards up to 20 lunar missions through its Commercial Lunar Payload Services (CLPS), this proposal illustrates not only a strategic use of resources but also an agile response to evolving opportunities in space exploration.

Future Technologies

5 Views

0 Comments

Write A Comment

*
*
Please complete the captcha to submit your comment.
Related Posts All Posts
09.28.2026

How New Formulation Makes RNA Vaccines More Heat-Resistant

Update Revolutionizing Vaccine Storage: The New RNA Solution In recent years, RNA vaccines have emerged as a critical tool in combating global health crises, particularly during the COVID-19 pandemic. But did you know that these vital vaccines typically require storage at frigid temperatures? This means they cannot be easily distributed to all parts of the globe, particularly remote areas without proper refrigeration facilities. Thankfully, researchers at MIT have developed a groundbreaking formulation that could change everything. Breaking the Cold Chain: Achieving Stability The prominent challenge with RNA vaccines lies in their fragility. They are delivered using lipid nanoparticles (LNPs)—tiny carriers that protect the RNA and enhance its ability to enter cells. However, these LNPs necessitate storage in extremely cold environments (-20 to -80 degrees Celsius), creating obstacles for broader distribution. To solve this issue, the MIT team has successfully created heat-resistant formulations that can remain stable at room temperature for up to a year or withstand temperatures nearing 100°F for two months. This remarkable advancement opens doors for vaccination in areas traditionally hard to reach. AI's Role in Vaccine Development: A Game Changer One of the most fascinating aspects of this emerging technology is the significant role artificial intelligence played in the research. The team leveraged machine learning to predict optimal formulations for the LNPs, reducing the need for numerous experimental trials. Ana Jaklenec, a principal investigator at MIT, noted, "The real beauty of this algorithm is that we can use it with small data sets." By optimizing the formulation process, the researchers not only accelerated the development timeline but also enhanced the chances of formulating heat-stable vaccines. This could lead to quicker responses to future health emergencies. Looking Ahead: The Future of Vaccination As the demand for vaccines continues to grow, the implications of this technology could be far-reaching. Imagine microneedle patches that could deliver vaccines through the skin without the need for refrigeration. The combination of heat stability and user-friendly delivery methods may revolutionize how we think about vaccinations. As illnesses like cancer are now targeted with RNA vaccines, developing practical solutions like this could be life-saving. Making Vaccine Accessibility a Reality The potential of these advancements cannot be overstated. Enabling vaccines to be stored at room temperature provides a promising path toward solving global health challenges. Delivering effective vaccines to remote areas will not only save lives but also empower populations by giving them access to preventative healthcare. The work being done at MIT showcases how innovative solutions can rise to meet the world's health needs. As we look forward to a future where equitable healthcare is within reach for everyone, understanding these types of technological developments in vaccine biotechnology is essential. They'll shape our health in significant ways, and the collaborative efforts of researchers and machine learning are making it all possible.

09.26.2026

Harnessing the Power of Phages: A New Frontier Against Bacterial Infections

Update Unlocking Nature's Antibacterial Arsenal Imagine a world where your body is a battlefield, filled with billions of bacterial soldiers, most of which are friendly, but some can turn deadly. In a groundbreaking move, researchers are harnessing bacteriophages, or phages, the viruses that specifically target bacteria, to help combat antibiotic-resistant infections. This innovative approach, spearheaded by the University of Colorado Anschutz School of Medicine, could revolutionize how we treat infections that are currently resistant to conventional treatments. The Rise of Antibiotic Resistance As our reliance on antibiotics grows, so does the ability of bacteria to adapt and resist these medications. The Centers for Disease Control and Prevention (CDC) has warned about the increasing threat of antibiotic-resistant bacteria, which now cause over 35,000 deaths each year in the United States alone. This alarming trend underscores an urgent need for alternative treatments—a role that phages could fulfill. How Phages Operate So, how do these minuscule viruses work? Unlike other viruses that can infect human cells, phages are harmless to us but highly effective against bacterial cells. They latch onto a bacterium, inject their genetic material, and hijack the bacterium's cellular machinery to replicate. This process often leads to the destruction of the bacterial cell, thereby clearing the infection. Researchers like Breck Duerkop have spent years creating a library of these phages, specifically targeting hardy strains like Enterococcus faecalis and Enterococcus faecium, which can wreak havoc, especially in immunocompromised individuals. What Makes Phage Therapy Exciting One key advantage of phage therapy is its specificity. Unlike antibiotics that may kill beneficial bacteria along with harmful strains, phages can be tailored to target specific bacteria, preserving the overall health of our microbiomes. In today's landscape of precision medicine, this tailored approach fits seamlessly into our evolving understanding of health. A Bright Future for Phage Research The potential for combining phage therapy with existing FDA-approved drugs opens new avenues for treating resistant infections. This dual approach might enhance treatment efficacy while minimizing side effects commonly associated with antibiotics. Moreover, as research progresses, phages may be engineered for enhanced effectiveness or stability, further solidifying their role in modern medicine. Conclusion: The Way Forward for Health The exploration of phages as an innovative solution for antibiotic resistance presents a hopeful future. As researchers delve deeper into the realm of phage therapy, ensuring thorough studies and patient safety will be paramount for its acceptance in clinical settings. By staying informed and supporting advancements in biotechnology, we can help pave the way for safer, more effective treatments.

09.25.2026

How AI is Revolutionizing Phage Therapy for Antibiotic Resistance

Update AI-Powered Solutions in the Fight Against Antibiotic Resistance Phage therapy, a promising method using viruses to target bacteria, is gaining traction as antibiotic resistance rises alarmingly worldwide. Biochemists at the University of Wisconsin–Madison have harnessed the potential of artificial intelligence (AI) to revolutionize how we combat these stubborn bacterial infections. By using AI models to guide mutations in bacteriophages—natural viruses that infect and destroy bacteria—researchers like professor Vatsan Raman are unlocking new ways to boost the efficacy of phage therapy, potentially offering alternatives to traditional antibiotics. What Is Phage Therapy and Why Is It Important? For decades, antibiotics have been our main defense against bacterial illnesses ranging from minor infections to life-threatening diseases. However, bacteria evolve rapidly, developing resistance to antibiotics faster than we can create new ones. This evolutionary arms race has made phage therapy particularly relevant as it utilizes the power of phages to target and eliminate specific bacteria that have become resistant to standard treatments. Phage therapy not only allows for targeted treatment but also has the potential to maintain beneficial bacteria in our microbiomes. How AI is Changing the Game The breakthrough in this research lies in the application of AI to identify mutations in phages that enhance their ability to infect bacteria. Raman's team developed an AI model capable of learning the evolutionary rules that govern successful phage behavior. By doing so, they were able to engineer phages that could infect their bacterial targets up to a staggering one million times more effectively than naturally occurring counterparts. In tests simulating real-world challenges in phage therapy development, the AI model has shown great promise by identifying specific mutations that not only improve infection rates but also allow for more targeted treatment strategies, preserving beneficial bacteria. Envisioning the Future of Phage Therapy By merging biology and technology, the path forward looks promising. The potential for phage therapy guided by AI could transform medical treatments and push back against the rising tide of antibiotic-resistant infections. With continued research and development, we might be on the brink of a new era in combating bacterial diseases. Imagine treatments that not only effectively eliminate harmful pathogens but also support overall gut health by sparing useful microbes. This dual benefit is crucial for holistic health strategies moving forward. Challenges and Opportunities Ahead Despite the exciting prospects, there remain several challenges in the widespread application of phage therapy. Regulatory issues, potential side effects, and ethical considerations related to genetic modifications of phages must be addressed. However, with advancements in biotechnology and ongoing research, overcoming these hurdles is within reach. As we learn more about how to effectively combat bacterial infections using AI and phage therapy, the potential impact on public health could be monumental, leading us to envision a future where antibiotic resistance is no longer a leading public health concern.

AiTechDigest

Your premier destination for the latest AI breakthroughs, emerging technologies, and future innovations shaping the world.

COMPANY

  • Privacy Policy
  • Terms of Use
  • Advertise
  • Contact Us
  • Menu 5
  • Menu 6




ABOUT US

We strive to keep you informed and inspired with the most cutting-edge development in artificial intelligence, robotics, quantum computing and beyond. 

© 2026 AITechDigest.Net - Powered by Eden Streams All Rights Reserved. 1317 Edgewater Dr #2368, Orlando, FL 32804 . Contact Us . Terms of Service . Privacy Policy

{"company":"AITechDigest.Net - Powered by Eden Streams","address":"1317 Edgewater Dr #2368","city":"Orlando","state":"FL","zip":"32804","email":"support@edensmail.com","tos":"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","privacy":"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"}

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*